Jianfei Fu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Positive Breast Cancer

Renal Cell Carcinoma

Top Venues

Cancer biology & therapy

OncoTargets and therapy

Cancer control : journal of the Moffitt Cancer Center

This page only lists publications with an associated author ORCID identifier.

Publications

Wanfen Tang, Chenghui Li, Dong Huang, Shishi Zhou, Hongjuan Zheng, Qinghua Wang, Xia Zhang, Jianfei Fu
NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis. Cancer biology & therapy 25 (1) (2024)
Wanfen Tang, Chenghui Li, Dong Huang, Shishi Zhou, Hongjuan Zheng, Qinghua Wang, Xia Zhang, Jianfei Fu
NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis. Cancer biology & therapy 25 (1) (2024)
Wanfen Tang, Chenghui Li, Dong Huang, Shishi Zhou, Hongjuan Zheng, Qinghua Wang, Xia Zhang, Jianfei Fu
NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis. Cancer biology & therapy 25 (1) (2024)
Qinghua Wang, Ruihua Yin, Xiaoxiao Chen, Bin Hu, Bingjing Jiang, Wanfen Tang, Xia Zhang, Xiayun Jin, Mingliang Ying, Jianfei Fu
Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma. Cancer control : journal of the Moffitt Cancer Center 30 (2023)
Hongjuan Zheng, Chenyang Ge, Haiping Lin, Shishi Zhou, Wanfen Tang, Qinghua Wang, Xia Zhang, Xiayun Jin, Xifeng Xu, Jinlin Du, Jianfei Fu
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PloS one 18 (1) (2023)
Hongjuan Zheng, Chenyang Ge, Haiping Lin, Shishi Zhou, Wanfen Tang, Qinghua Wang, Xia Zhang, Xiayun Jin, Xifeng Xu, Jinlin Du, Jianfei Fu
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PloS one 18 (1) (2023)
Hongjuan Zheng, Chenyang Ge, Haiping Lin, Shishi Zhou, Wanfen Tang, Qinghua Wang, Xia Zhang, Xiayun Jin, Xifeng Xu, Jinlin Du, Jianfei Fu
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PloS one 18 (1) (2023)
Ting Jiang, Hongjuan Zheng, Ke Dong, Wen Guanghua, Shishi Zhou, Chenghui Li, Mengjie Dong, Jianfei Fu
The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report. The Journal of international medical research 51 (4) (2023)
Hongjuan Zheng, Chenyang Ge, Haiping Lin, Shishi Zhou, Wanfen Tang, Qinghua Wang, Xia Zhang, Xiayun Jin, Xifeng Xu, Jinlin Du, Jianfei Fu
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PloS one 18 (1) (2023)
Hongjuan Zheng, Chenyang Ge, Haiping Lin, Shishi Zhou, Wanfen Tang, Qinghua Wang, Xia Zhang, Xiayun Jin, Xifeng Xu, Jinlin Du, Jianfei Fu
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups. PloS one 18 (1) (2023)
Liang Fu, Lin Chen, Rufang Li, Wenxia Xu, Jianfei Fu, Xianghong Ye
Metabolomics studies on cachexia in patients with cancer: a scoping review protocol. BMJ open 12 (4) (2022)
Hongjuan Zheng, Chenyang Ge, Haiping Lin, Lunpo Wu, Qinghua Wang, Shishi Zhou, Wanfen Tang, Xia Zhang, Xiayun Jin, Xifeng Xu, Zhongwu Hong, Jianfei Fu, Jinlin Du
Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer. International journal of clinical oncology 27 (7) (2022)
Bingxin Song, Shishi Zhou, Chenghui Li, Hongjuan Zheng, Xia Zhang, Xiayun Jin, Jianfei Fu, Huixian Hu
A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors. International journal of general medicine 15 (2022)
Shishi Zhou, Wanfen Tang, Qinghua Wang, Xia Zhang, Xiayun Jin, Xifeng Xu, Jianfei Fu
A Case Report: Cutaneous Metastasis of Advanced Rectal Cancer with BRAF Mutation. OncoTargets and therapy 14 (2021)
Xiaoya Zhao, Jianfei Fu, Wanfen Tang, Liangliang Yu, Wenxia Xu
Inhibition of Serine Metabolism Promotes Resistance to Cisplatin in Gastric Cancer. OncoTargets and therapy 13 (2020)